Pfizer (PFE) EV to EBITDA (2009 - 2026)
Pfizer's (PFE) EV to EBITDA stood at 5.77 in Q3 2026, up 29.3% from 4.47 a year earlier and up 22.6% from the prior quarter.
Powered by 
Analysis
Pfizer (PFE) EV to EBITDA (2009 - 2026) Analysis & Trends
On a TTM basis, Pfizer's EV to EBITDA came in at 4.29 as of Sep 27, 2026, up 66.8% year-over-year; for FY2025, it was 4.70, down 10.5% from FY2024.
- Across earlier years, EV to EBITDA came in at 5.25 in FY2024 (-56.4%), 12.02 in FY2023 (+105.6%), 5.84 in FY2022 (-38.3%) and 9.48 in FY2021 (-16.9%).
- The Q3 2026 figure is the highest quarterly EV to EBITDA since Q3 2024.
- On a year-over-year basis, EV to EBITDA rose in two of the last eight quarters, with an average decline of 27.5%.
- Peak year-over-year performance for EV to EBITDA in the last five years was growth of 228.6% in Q2 2024, against a decline of 70.8% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 4.71 (Q2 2026), 5.09 (Q1 2026) and 4.69 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 139.96 Bn | 111.95 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2026 | 5.77 |
| Jun 28, 2026 | 4.71 |
| Mar 29, 2026 | 5.09 |
| Dec 31, 2025 | 4.69 |
| Sep 28, 2025 | 4.47 |
| Jun 29, 2025 | 4.64 |
| Mar 30, 2025 | 5.21 |
| Dec 31, 2024 | 5.25 |
| Sep 29, 2024 | 8.64 |
| Jun 30, 2024 | 15.89 |
| Mar 31, 2024 | 13.89 |
| Dec 31, 2023 | 11.97 |
| Oct 1, 2023 | 6.58 |
| Jul 2, 2023 | 4.84 |
| Apr 2, 2023 | 4.92 |
| Dec 31, 2022 | 5.84 |
| Oct 2, 2022 | 4.64 |
| Jul 3, 2022 | 6.06 |
| Apr 3, 2022 | 7.22 |
| Dec 31, 2021 | 9.47 |
API Access
Pfizer EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();